Correlation Between Neurosense Therapeutics and XORTX Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurosense Therapeutics and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurosense Therapeutics and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurosense Therapeutics and XORTX Therapeutics, you can compare the effects of market volatilities on Neurosense Therapeutics and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurosense Therapeutics with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurosense Therapeutics and XORTX Therapeutics.

Diversification Opportunities for Neurosense Therapeutics and XORTX Therapeutics

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Neurosense and XORTX is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Neurosense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurosense Therapeutics are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Neurosense Therapeutics i.e., Neurosense Therapeutics and XORTX Therapeutics go up and down completely randomly.

Pair Corralation between Neurosense Therapeutics and XORTX Therapeutics

Given the investment horizon of 90 days Neurosense Therapeutics is expected to generate 0.63 times more return on investment than XORTX Therapeutics. However, Neurosense Therapeutics is 1.59 times less risky than XORTX Therapeutics. It trades about 0.02 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  155.00  in Neurosense Therapeutics on September 2, 2024 and sell it today you would lose (57.00) from holding Neurosense Therapeutics or give up 36.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neurosense Therapeutics  vs.  XORTX Therapeutics

 Performance 
       Timeline  
Neurosense Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Neurosense Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
XORTX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XORTX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Neurosense Therapeutics and XORTX Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurosense Therapeutics and XORTX Therapeutics

The main advantage of trading using opposite Neurosense Therapeutics and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurosense Therapeutics position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.
The idea behind Neurosense Therapeutics and XORTX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets